Timo Strandberg
0000-0001-6299-925X
Publication & Citation Trends
Publications
0 total
Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes
Cited by 1
Semantic Scholar
Weight loss therapies and osteoporosis risk.
Cited by 0
Semantic Scholar
Product labels downplay the safety of statin therapy: evidence from randomised controlled trials.
Cited by 0
Semantic Scholar
Increased intestinal mucosal permeability and metabolic endotoxemia predict the risk of cardiovascular mortality. OA
Cited by 4
Semantic Scholar
Hippocratic considerations about statin treatment for patients over 75 years of age
Cited by 3
Semantic Scholar
Drugs for dyslipidaemia: the legacy effect of the Scandinavian Simvastatin Survival Study (4S).
Cited by 20
Semantic Scholar
Heart-healthy diets including phytostanol ester consumption to reduce the risk of atherosclerotic cardiovascular diseases. A clinical review OA
Cited by 8
Semantic Scholar
Research Topics
Frailty in Older Adults
(124)
Dementia and Cognitive Impairment Research
(114)
Lipoproteins and Cardiovascular Health
(114)
Nutrition and Health in Aging
(107)
Health Systems, Economic Evaluations, Quality of Life
(100)
Affiliations
Helsinki Metropolia University of Applied Sciences
Oslo University Hospital
Centre National de la Recherche Scientifique
St. Michael's Hospital
European Union